Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
Gene Nudelman, CEO at Core Scientific Creations Ltd, shared a post on LinkedIn:
“Early hemorrhage control isn’t just about stopping bleeding – it’s about improving patient outcomes.
Every minute of uncontrolled bleeding increases the risk of hemorrhagic shock, coagulopathy, organ dysfunction, greater transfusion requirements, and mortality. That’s why time to hemostasis is one of the most important factors in trauma and surgical care.
Our latest white paper explores how WoundClot supports early hemorrhage management across the continuum of care—from the point of injury and emergency departments to operating rooms, postoperative care, vascular access, and austere environments.
Key highlights include:
- Broad-spectrum use across appropriate accessible bleeding environments
- FDA-cleared in the U.S. as a hemostatic wound dressing and used internationally as a Class III implantable and bioresorbable surgical hemostat in over 50 countries
- More than a decade of clinical and commercial use with no reported product-related adverse events in company post-market surveillance
- A unique expanding gel-matrix technology that conforms to complex wounds, adheres to tissue, and helps create an effective localized hemostatic environment
- Evidence supporting the importance of earlier hemostasis in reducing mortality and major complications
The goal isn’t simply to stop bleeding – it’s to control hemorrhage early enough to prevent avoidable deterioration.
Every minute matters. Every drop counts.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 16:11David C. Madoff: HCC With Portal Vein Tumor Thrombosis East vs West
-
Oct 10, 2026, 15:50M Velia Antonini: ECMO Cannula Design and Its Impact on Blood Flow, Thrombosis and Hemolysis
-
Oct 10, 2026, 15:14Cihan Ay: PhD With Distinction in Thrombosis Research in Patients With Primary Brain Tumors
-
Oct 10, 2026, 15:07Khalid Ahmed: Mortality and Survival in Young People With Sickle Cell Disease and Beta Thalassaemia in England 1997 to 2025
-
Oct 10, 2026, 14:59Matteo Foschi: Antithrombotic Therapy in Secondary Stroke Prevention 10 Clinical Pearls Every Clinician Should Know
-
Oct 10, 2026, 14:33Ahmad Gharehbaghian: Supporting Blood Transfusion Teams and Strengthening Iran’s Blood Supply
-
Oct 10, 2026, 14:17Caitlin Raymond: Long-Term Infection Risk With ECP in GVHD
-
Oct 10, 2026, 14:09Emmanuel J Favaloro: 100 years of von Willebrand Disease in 2026
-
Oct 10, 2026, 13:54WFH Strengthens Collaboration to Advance Hemophilia Care in Paraguay